Thought to arise as a consequence of chronic inflammation in metabolic disease, a dampened ability to mount IFN responses during obesity may also be epigenetically controlled, since the transcriptional phenotype persisted in organoid culture, and chromatin accessibility was restricted at associated TF binding sites. This evidence concerns the gene TF and Other metabolic disease.